2012•Chinese Journal of Health Laboratory TechnologyRequires access

Study on genotypes of extended spectrum β-lactamases and antibiotic resistance of Proteus mirabilis strains

Xianjun Wang

Open publisher page 0 citations

Abstract

Objective:To understand the antibiotic resistance,distribution of nosocomial infections and genotypes of extended spectrum β-1actamases of Proteus mirabilis strains isolated from clinical specimens.Methods: A total of 105 strains of Proteus mirabilis were analysed for their antimicrobial susceptibility.The gene of ESBLs-producing isolates were detected by PCR and then sequenced.Results: None of these Proteus mirabilis isolates was found resistant to imipenem,mempenem and cefoxitin,while their drug resistance rates to ciprofloxacin,levofloxacin and the third-generation cephalosporins were at low level,17(16.2%) strains were identified as ESBls producers.The genotypes of these strains included CTX-M-14(14/17),CTX-M-15(3/17).Conclusion: The detection rate of ESBL-producing Proteus mirabilis was still low.17 strains of ESBL-producing Proteus mirabilis,with the genotype of CTX-M-15 and CTX-M-14,were resistant to many antibacterial agents.More attention should be paid to survey such strains.

About this research paper

What this paper is about

Objective:To understand the antibiotic resistance,distribution of nosocomial infections and genotypes of extended spectrum β-1actamases of Proteus mirabilis strains isolated from clinical specimens.Methods: A total of 105 strains of Proteus mirabilis were analysed for their antimicrobial susceptibility.The gene of ESBLs-producing isolates were detected by PCR and then sequenced.Results: None of these Proteus mirabilis isolates was found resistant to imipenem,mempenem and cefoxitin,while their drug resistance rates to ciprofloxacin,levofloxacin and the third-generation cephalosporins were at low level,17(16.2%) strains were identified as ESBls producers.The genotypes of these strains included CTX-M-14(14/17),CTX-M-15(3/17).Conclusion: The detection rate of ESBL-producing Proteus mirabilis was still low.17 strains of ESBL-producing Proteus mirabilis,with the genotype of CTX-M-15 and CTX-M-14,were resistant to many antibacterial agents.More attention should be paid to survey such strains.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To understand the antibiotic resistance,distribution of nosocomial infections and genotypes of extended spectrum β-1actamases of Proteus mirabilis strains isolated from clinical specimens.Methods: A total of 105 strains of Proteus mirabilis were analysed for their antimicrobial susceptibility.The gene of ESBLs-producing isolates were detected by PCR and then sequenced.Results: None of these Proteus mirabilis isolates was found resistant to imipenem,mempenem and cefoxitin,while their drug resistance rates to ciprofloxacin,levofloxacin and the third-generation cephalosporins were at low level,17(16.2%) strains were identified as ESBls producers.The genotypes of these strains included CTX-M-14(14/17),CTX-M-15(3/17).Conclusion: The detection rate of ESBL-producing Proteus mirabilis was still low.17 strains of ESBL-producing Proteus mirabilis,with the genotype of CTX-M-15 and CTX-M-14,were resistant to many antibacterial agents.More attention should be paid to survey such strains.

Key concepts: Proteus mirabilis, Cefoxitin, Microbiology, Proteus, Ciprofloxacin, Biology, Imipenem, Genotype

Related papers

Back to paper searchBrowse research topicsOriginal source
Study on genotypes of extended spectrum β-lactamases and antibiotic resistance of Proteus mirabilis strains — Research Paper | ScholarLens